{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:34:30Z","timestamp":1780050870561,"version":"3.53.1"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>Cerebrospinal fluid (CSF) specific oligoclonal bands (OCB) are a key diagnostic marker in multiple sclerosis (MS). Recent studies suggest that OCB reduction may reflect treatment efficacy and propose it as a potential endpoint in trials with chimeric antigen receptor (CAR) T-cell therapy. However, the prognostic value of baseline OCB count remains unclear. This study analyzed data from 454 persons (314 had MS, 140 clinically isolated syndrome). OCB analysis was performed by isoelectric focusing in polyacrylamide gel, followed by silver staining. The correlation of the number of OCBs with clinical and paraclinical parameters as well as follow-up outcomes was evaluated. Our results showed that in OCB positive persons with MS, the median number of CSF specific bands was 19. No significant correlation was found between OCB count and age, sex, initial EDSS, or MRI lesion load. OCB count also did not predict relapse risk or EDSS progression. However, strong correlations were observed with intrathecal synthesis of IgG and kappa free light chains. Therefore, our conclusion is that OCB count does not reflect clinical disease activity at diagnosis nor predict clinical progression within the observed median follow-up period of 9\u202fmonths. Whether a decrease in OCB count indicates reduced humoral immune response in the CNS under certain therapies remains unclear and requires further prospective studies.<\/jats:p>","DOI":"10.3389\/fneur.2026.1719470","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:05:42Z","timestamp":1776427542000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Assessing the value of oligoclonal band count in multiple sclerosis: insights from a large cohort analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Konstantin F.","family":"Jendretzky","sequence":"first","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Wurster","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz Felix","family":"Konen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"D\u00f6ring","sequence":"additional","affiliation":[{"name":"Institute for Diagnostic and Interventional Neuroradiology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jule Finia","family":"Friedrich","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Nay","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"M\u00f6hn","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Grote-Levi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"H\u00fcmmert","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt-Wolfram","family":"S\u00fchs","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schwenkenbecher","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gingele","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Skripuletz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Hannover Medical School","place":["Hannover, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann Neurol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","article-title":"Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald criteria\u201d","volume":"58","author":"Polman","year":"2005","journal-title":"Ann Neurol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/S1474-4422(25)00270-4","article-title":"Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria","volume":"24","author":"Montalban","year":"2025","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/S1474-4422(18)30160-1","article-title":"Applying the 2017 McDonald diagnostic criteria for multiple sclerosis","volume":"17","author":"Schwenkenbecher","year":"2018","journal-title":"Lancet Neurol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1001\/jamaneurol.2018.2160","article-title":"Application of the 2017 revised McDonald criteria for multiple sclerosis to patients with a typical clinically isolated syndrome","volume":"75","author":"van der Vuurst De Vries","year":"2018","journal-title":"JAMA Neurol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.msard.2018.07.035","article-title":"Establishing the diagnosis of multiple sclerosis in Croatian patients with clinically isolated syndrome: 2010 versus 2017 McDonald criteria","volume":"25","author":"Habek","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"102043","DOI":"10.1016\/j.msard.2020.102043","article-title":"Application of the 2017 McDonald criteria for the diagnosis of multiple sclerosis after a first demyelinating event in patients from Argentina","volume":"41","author":"Cassar\u00e1","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s004150200026","article-title":"Oligoclonal bands and antibody responses in multiple sclerosis","volume":"249","author":"Correale","year":"2002","journal-title":"J Neurol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.autrev.2005.03.005","article-title":"The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)","volume":"4","author":"Ziemssen","year":"2005","journal-title":"Autoimmun Rev"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1136\/jnnp.57.8.897","article-title":"Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report","volume":"57","author":"Andersson","year":"1994","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.3390\/ijms19123796","article-title":"The persisting significance of oligoclonal bands in the dawning era of kappa free light chains for the diagnosis of multiple sclerosis","volume":"19","author":"Schwenkenbecher","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"577108","DOI":"10.1016\/j.jneuroim.2019.577108","article-title":"Cerebrospinal fluid free light chains compared to oligoclonal bands as biomarkers in multiple sclerosis","volume":"339","author":"Gaetani","year":"2020","journal-title":"J Neuroimmunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1177\/1352458514538111","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of multiple sclerosis patients: a longitudinal study","volume":"20","author":"Mancuso","year":"2014","journal-title":"Mult Scler"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1177\/1352458511428465","article-title":"Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients","volume":"18","author":"von Glehn","year":"2012","journal-title":"Mult Scler"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10072-024-07930-w","article-title":"Effects of natalizumab on oligoclonal bands in the cerebrospinal fluid of patients with multiple sclerosis: a systematic review and meta-analysis","volume":"46","author":"Liampas","year":"2024","journal-title":"Neurol Sci"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.msard.2018.10.006","article-title":"Cladribine induces long lasting oligoclonal bands disappearance in relapsing multiple sclerosis patients: 10-year observational study","volume":"27","author":"Rejdak","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"uxae116","DOI":"10.1093\/cei\/uxae116","article-title":"Effects of cladribine on intrathecal and peripheral B and plasma cells","volume":"219","author":"Allen-Philbey","year":"2025","journal-title":"Clin Exp Immunol"},{"key":"ref21","article-title":"Phase 1, open-label, single center study of KYV-101, an autologous fully-human anti-CD19 chimeric antigen receptor T cell (CD19 CAR T) therapy, in participants with treatment refractory progressive multiple sclerosis","author":"Cree","year":"2024"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1001\/archneur.58.12.2044","article-title":"Oligoclonal band number as a marker for prognosis in multiple sclerosis","volume":"58","author":"Avasarala","year":"2001","journal-title":"Arch Neurol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"105391","DOI":"10.1016\/j.msard.2023.105391","article-title":"The role of oligoclonal band count and IgG index in treatment response and disease activity in multiple sclerosis","volume":"83","author":"Ta\u015fk\u0131ran","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"102382","DOI":"10.1016\/j.msard.2020.102382","article-title":"Impact of intrathecal IgG synthesis on neurological disability in patients with multiple sclerosis","volume":"45","author":"Akaishi","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1177\/1352458514568827","article-title":"Conversion from clinically isolated syndrome to multiple sclerosis: a large multicentre study","volume":"21","author":"Kuhle","year":"2015","journal-title":"Mult Scler J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1093\/brain\/awv105","article-title":"Defining high, medium and low impact prognostic factors for developing multiple sclerosis","volume":"138","author":"Tintore","year":"2015","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms18102061","article-title":"Clinically isolated syndrome according to McDonald 2010: intrathecal IgG synthesis still predictive for conversion to multiple sclerosis","volume":"18","author":"Schwenkenbecher","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1038\/s41598-024-57199-4","article-title":"Clinical and paraclinical characteristics of optic neuritis in the context of the McDonald criteria 2017","volume":"14","author":"Jendretzky","year":"2024","journal-title":"Sci Rep"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/135245859800400302","article-title":"Cerebrospinal fluid-physiology, analysis and interpretation of protein patterns for diagnosis of neurological diseases","volume":"4","author":"Reiber","year":"1998","journal-title":"Mult Scler"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1002\/elps.1150090304","article-title":"Comparison of oligoclonal immunoglobulin G bands in multiple sclerosis cerebrospinal fluid by immunoblotting and immunofixation","volume":"9","author":"Mehta","year":"1988","journal-title":"Electrophoresis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/elps.201400339","article-title":"Capillary isoelectric focusing immunoassay as a new nanoscale approach for the detection of oligoclonal bands","volume":"36","author":"Halbgebauer","year":"2015","journal-title":"Electrophoresis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archneur.62.6.865","article-title":"Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement","volume":"62","author":"Freedman","year":"2005","journal-title":"Arch Neurol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/j.1468-1331.2007.01859.x","article-title":"Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis","volume":"14","author":"Koch","year":"2007","journal-title":"Eur J Neurol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1177\/13524585221134217","article-title":"Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: a consensus statement","volume":"29","author":"Hegen","year":"2022","journal-title":"Mult Scler J"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"4800","DOI":"10.1007\/s00415-023-11817-9","article-title":"Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis","volume":"270","author":"Rosenstein","year":"2023","journal-title":"J Neurol"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"117471","DOI":"10.1016\/j.cca.2023.117471","article-title":"Biochemical biomarkers for multiple sclerosis","volume":"548","author":"Maroto-Garc\u00eda","year":"2023","journal-title":"Clin Chim Acta"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1136\/jnnp.2008.150896","article-title":"CSF oligoclonal band status informs prognosis in multiple sclerosis: a case control study of 100 patients","volume":"80","author":"Joseph","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1719470\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:05:43Z","timestamp":1776427543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2026.1719470\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":37,"alternative-id":["10.3389\/fneur.2026.1719470"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2026.1719470","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1719470"}}